NPPA and myeloid sarcoma: The evidence of subjects with MS found by Monaco et al. [33,34,35] that the Trp levels are lower in the serum and CSF corresponds with more recent results regarding depressed TRP levels in the serum and CSF of MS patients, proving the activation of KP in MS.